GNRO.PA
Price:
$0.0454
Market Cap:
$1.34M
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody, which has completed Phase IIb clinical trial for multiple sclerosis; and is in Phase IIa to treat type 1 diabetes, as well as is in Phase I for the treatment of chronic inflammatory demyelinating polyneuropathy. It has cooperative research and development agreements with The National Institute of Neurological Disorders and Stroke to develop novel therapeutic antibodies for the treatment of amyotrophic lateral sclerosis; and Academic labs to develop inflammatory psychosis, as well as...[Read more]
Industry
Biotechnology
IPO Date
2016-04-15
Stock Exchange
PAR
Ticker
GNRO.PA
According to GeNeuro S.A.’s latest financial reports and current stock price. The company's current Enterprise Value is 12.88M. This represents a change of -67.98% compared to the average of 40.22M of the last 4 quarters.
The mean historical Enterprise Value of GeNeuro S.A. over the last ten years is 39.40M. The current 12.88M Enterprise Value has changed 3.17% with respect to the historical average. Over the past ten years (40 quarters), GNRO.PA's Enterprise Value was at its highest in in the December 2012 quarter at 148.30M. The Enterprise Value was at its lowest in in the June 2015 quarter at -2718838.57.
Average
39.40M
Median
35.36M
Minimum
238.95K
Maximum
144.17M
Discovering the peaks and valleys of GeNeuro S.A. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 21.35%
Maximum Annual Enterprise Value = 144.17M
Minimum Annual Increase = -99.79%
Minimum Annual Enterprise Value = 238.95K
| Year | Enterprise Value | Change |
|---|---|---|
| 2023 | 38.62M | 20.31% |
| 2022 | 32.10M | -54.97% |
| 2021 | 71.28M | 40.77% |
| 2020 | 50.64M | -9.70% |
| 2019 | 56.08M | 21.35% |
| 2018 | 261.49K | 9.43% |
| 2017 | 238.95K | -17.52% |
| 2016 | 289.70K | -5.01% |
| 2015 | 304.99K | -99.79% |
| 2014 | 144.17M | -1.60% |
The current Enterprise Value of GeNeuro S.A. (GNRO.PA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
47.33M
5-year avg
49.74M
10-year avg
39.40M
GeNeuro S.A.’s Enterprise Value is less than Abivax S.A. (7.38B), less than OSE Immunotherapeutics S.A. (142.05M), less than Sensorion S.A. (46.54M), less than GenSight Biologics S.A. (36.30M), less than Transgene S.A. (135.53M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 7.38B | $7.35B | |
| 142.05M | $112.67M | |
| 46.54M | $91.64M | |
| 36.30M | $19.65M | |
| 135.53M | $121.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeNeuro S.A. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GeNeuro S.A. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is GeNeuro S.A.'s Enterprise Value?
What is the highest Enterprise Value for GeNeuro S.A. (GNRO.PA)?
What is the 3-year average Enterprise Value for GeNeuro S.A. (GNRO.PA)?
What is the 5-year average Enterprise Value for GeNeuro S.A. (GNRO.PA)?
How does the current Enterprise Value for GeNeuro S.A. (GNRO.PA) compare to its historical average?